GNE-616 - Moligand™ , Channel blocker of Na v1.1;Channel blocker of Na v1.2;Channel blocker of Na v1.3;Channel blocker of Na v1.4;Channel blocker of Na v1.5;Channel blocker of Na v1.6;Channel blocker of Na v1.7, CAS No.G610616, Channel blocker of Na v1.1;Channel blocker of Na v1.2;Channel blocker of Na v1.3;Channel blocker of Na v1.4;Channel blocker of Na v1.5;Channel blocker of Na v1.6;Channel blocker of Na v1.7
GNE-616 - Moligand™ , Channel blocker of Na v1.1;Channel blocker of Na v1.2;Channel blocker of Na v1.3;Channel blocker of Na v1.4;Channel blocker of Na v1.5;Channel blocker of Na v1.6;Channel blocker of Na v1.7, CAS No.G610616, Channel blocker of Na v1.1;Channel blocker of Na v1.2;Channel blocker of Na v1.3;Channel blocker of Na v1.4;Channel blocker of Na v1.5;Channel blocker of Na v1.6;Channel blocker of Na v1.7
GRADE & PURITYMoligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Moligand™ Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Room temperature Ships Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Specifications
Sinonimi
compound 24;GNE616
Specifiche e purezza
Moligand™
Condizioni di conservazione di stoccaggio
Room temperature
Grado
Moligand™
Tipo di azione
CHANNEL BLOCKER
Meccanismo d'azione
Channel blocker of Na v1.1;Channel blocker of Na v1.2;Channel blocker of Na v1.3;Channel blocker of Na v1.4;Channel blocker of Na v1.5;Channel blocker of Na v1.6;Channel blocker of Na v1.7
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Recensioni
Recensioni dei clienti
Application Protocols
No vendor-tested application protocols are provided for this item.
General protocol templates (to be adapted to your assay)
Biochemical enzyme assay: Prepare 10 mM DMSO stock; perform an 11-point 1:3 serial dilution to span desired nM–µM range; keep final DMSO at 0.5% v/v. Include no-enzyme, no-substrate, and vehicle controls.
Cell-based assay: Dose from intermediate DMSO stocks to ≤0.1–0.5% v/v final; pre-equilibrate compound in complete media for 10–15 min before addition to cells to reduce edge precipitation.
Thermal shift (DSF): Mix protein with dye and compound at 2–10× over KD estimate; scan and analyze Tm shifts relative to vehicle.
Record-keeping
Document lot number, stock concentration, diluent, plate map, and instrument settings. Archive raw data and analysis scripts for reproducibility.
These are generic research templates; adjust for your system and consult relevant SOPs.
Biological Roles
Item-specific biological roles, targets, or pathways are not provided for GNE-616 in the Product Data.
General considerations for small-molecule probes/tools
Potential roles in research include serving as tool compounds to interrogate enzyme or receptor function, modulate signaling pathways, or act as chemical starting points for SAR exploration.
Any observed phenotype should be corroborated with orthogonal chemotypes, genetic perturbation (knockdown/knockout), and concentration–response analysis to avoid misattribution.
Consider common artifacts: aggregation, redox cycling, fluorescence interference, and PAINS substructures. Use counter-screens and detergent challenges where appropriate.
Documentation
Record exact lot numbers, solvent vehicle, and exposure times. If using external database targets (e.g., from PubChem CID 138393286), verify that the structural record matches this specific supplier lot before assigning biological activity.
Compliance
Supplied strictly for research use only; not for use in humans or clinical diagnostics.
Buffer Applications
This product is a small-molecule research compound and is not a buffering agent. However, practical notes for use in buffered systems apply:
Prepare concentrated DMSO stocks (e.g., 10–50 mM), then dilute into assay buffers such as PBS, HEPES, Tris, or assay-specific media.
Maintain final DMSO ≤0.1–1% v/v depending on biological tolerance; match vehicle in all controls.
Pre-wet with organic solvent before adding to aqueous buffers to reduce precipitation. Add slowly with vigorous mixing; brief sonication can help.
For pH-sensitive assays, verify that the compound or its counterions (if any) do not alter buffer pH; use high-capacity buffers when dosing at higher micromolar concentrations.
If adsorption to plastics is suspected, consider low-binding plates or include inert carriers (e.g., 0.01–0.05% Tween-20) if compatible with the assay.
Green Alternatives
Because the molecular structure and processing history are not specified, green considerations center on solvent and workflow choices rather than the substance itself.
Greener practices (general)
Prefer bio-based or safer solvents for dissolution and cleaning where compatible with solubility and stability.
Minimize DMSO concentration in assays by preparing higher-concentration stocks and diluting to ≤0.1–0.5% v/v final.
Use microscale formats (96/384-well) and miniaturized analytics (UPLC) to reduce solvent usage.
DMSO: excellent solvency; not green, high boiling; manage waste carefully.
2-MeTHF vs THF: 2-MeTHF offers better safety/renewable sourcing for synthetic steps; may be useful if derivatization or formulation research is performed around the scaffold.
Ethyl acetate vs dichloromethane: EtOAc is a greener extraction solvent; consider where polarity allows.
Operational improvements
Implement closed-well dispensing (acoustic or positive-displacement) to reduce evaporation and exposure.
Consolidate waste streams and use in-line solvent purification or on-demand stock prep to curb overproduction and aging of solutions.
Note: For item-specific green metrics (e.g., Process Mass Intensity in upstream synthesis), structural and route information would be required and is not available here.
Pharmaceutical Uses
Item-specific formulation or pharmacopeial status is not provided for this product. The compound is supplied for research use only and is not intended for human or veterinary use.
General R&D context
Early discovery groups may use such compounds for pre-formulation research, solubility screening, and stability studies (pH, light, oxidative, thermal) to understand developability of a scaffold series.
When conducting enabling studies (e.g., permeability, metabolic stability), document exact lot, salt form, and polymorph, as these greatly influence readouts.
Excipient compatibility screens (e.g., with Captisol, HP-β-CD, PEGs, polysorbates) can identify suitable vehicles for in vivo research in non-clinical settings; ensure compliance with institutional animal care policies and regulatory rules.
Note: No pharmacopeial monograph, dosage form guidance, or clinical application is stated or implied for this item.
Physical Properties
Item-specific values
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point / Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
Density, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Solubility (water/organic): Not specified for this item; refer to CoA/Spec Sheet.
logP / pKa: Not specified for this item; refer to CoA/Spec Sheet.
Practical implications (general guidance for small-molecule library compounds)
Stock solutions are commonly prepared at 10–50 mM in anhydrous DMSO, then diluted into assay buffers; assess solubility visually and by UV/LC where possible.
If poor DMSO solubility is observed, co-solvents such as DMF, ethanol, or acetonitrile can be screened; pH adjustment of aqueous media may aid dissolution for ionizable compounds.
For hygroscopic or polymorphic solids, physical properties (e.g., melting range) can shift with moisture content; handle quickly in low-humidity conditions and close containers promptly.
Verification tips
Confirm identity and purity by LC–MS and, where possible, 1H NMR prior to critical studies.
Record solution stability (freeze–thaw tolerance, light sensitivity) under your conditions, as these are highly structure- and matrix-dependent.
Quality and Grades
Item-specific
Grade: Moligand™ (from Product Data).
Purity and analytical specs: Not specified for this item; refer to CoA/Spec Sheet.
About Moligand™ (general description)
Moligand-tier materials are intended for screening and discovery workflows where consistent identity and usability (e.g., DMSO stock preparation) are priorities. In many screening libraries, suppliers verify identity by LC–MS and may support optional orthogonal methods (e.g., NMR); exact tests and thresholds vary by item and lot.
For plate-based assays and HTS/biochemical profiling, low levels of residual inorganic salts, polymeric binders, and volatile impurities are generally preferred to minimize assay interference; check the CoA for this item’s details.
Practical recommendations
Request or review the lot-specific CoA for: identification method(s), purity basis (area% by LC, qNMR, or weight%), and residual solvent profile.
If ultra-low UV background is needed (e.g., HPLC reference standards), consider inquiring about chromatography-grade or reference-standard grade availability; Moligand™ is typically aimed at research screening rather than metrological standards.
Reaction and Applications
Item-specific reactivity and application claims are not provided for this compound.
General research applications for library small molecules
Hit identification and validation: Use as a test article in biochemical, biophysical (e.g., DSF, MST, ITC), and cell-based assays to assess activity and SAR trends within a screening set.
Profiling and selectivity: Evaluate against off-target panels (e.g., kinases, GPCRs, ion channels) where relevant to your project. Record curve class, Hill slope, and assay interference flags.
Mechanism-of-action studies: Pair with target engagement readouts (CETSA, NanoBRET) and chemical proteomics when appropriate. Confirm on-target effects with orthogonal assays.
Analytical characterization: Establish stability-indicating methods (LC–MS, UPLC-PDA) to monitor degradation during storage and in assay matrices.
Practical tips
Prepare fresh DMSO stocks for critical assays; aliquot to avoid freeze–thaw cycles.
Include vehicle controls and, where possible, matched positive/negative control ligands.
Track solubility limits and visible precipitation upon dilution; perform post-dilution centrifugation/filtration when quantitation is critical.
Note: Without structural data, no specific synthetic transformations or named-reaction suitability can be inferred for this item.
Reaction Conditions
No item-specific reaction or transformation data are provided for this compound.
General conditions relevant to handling small-molecule tools rather than transforming them
Stock preparation: 10–50 mM in dry DMSO; vortex and, if needed, warm gently (<40 °C) or sonicate to assist dissolution. Filter (0.2 µm) for assays requiring sterility/clarity.
Assay dosing: Typical final 0.1–1% v/v DMSO; allow equilibration (5–30 min) post-dosing for binding/partitioning before readout, as appropriate for the assay.
Stability checks: Incubate at experimental temperature and collect time-course LC–MS to monitor degradation or adsorption losses.
If synthetic transformations are planned once the structure is confirmed
Choose conditions aligned to the functional groups present (e.g., Pd-catalyzed cross-couplings in dioxane or MeCN; amide formations using HATU/EDC in DMF or greener alternatives like EtOAc/2-MeTHF when feasible).
Monitor reactions by UPLC–MS; target conversions >90% prior to isolation to reduce purification burden.
All values above are general literature practices and not specifications for this item.
Safety and Handling
Item-specific safety
GHS Classification / Signal Word / Pictograms / H-Statements: Not specified for this item; refer to SDS.
General laboratory precautions (not a substitute for the SDS)
Handle in a chemical fume hood wearing appropriate PPE: lab coat, safety glasses, and chemically resistant gloves (e.g., nitrile). Avoid inhalation of dust/vapors and contact with skin/eyes.
Prevent cross-contamination: use dedicated spatulas, recap immediately, and record opening dates for stability tracking.
Avoid incompatible conditions typical for organic small molecules: strong oxidizers, strong acids/bases, and ignition sources for volatile organics. Unknown dust explosivity warrants conservative handling—minimize dust formation.
First-aid overview (general)
Skin/eye contact: rinse with water for at least 15 minutes and remove contaminated clothing; seek medical attention as needed.
Inhalation: move to fresh air; obtain medical attention if symptoms occur.
Ingestion: rinse mouth; do not induce vomiting; seek medical attention.
Disposal
Dispose of contents/container according to local regulations for organic laboratory chemicals. Segregate halogenated and non-halogenated solvent waste.
Always consult the product-specific SDS for authoritative hazard, exposure controls, and transport information.
Solvent Selection
Item-specific solubility data are not provided for this compound; select solvents empirically based on your assay and analytical needs.
General guidance for small-molecule research compounds
Primary vehicle: DMSO (anhydrous) for 10–50 mM stocks; filter-sterilize if required by assay.
Alternative vehicles: DMF, ethanol, acetonitrile, or 2-propanol may aid dissolution; avoid water until the compound is fully wetted by an organic solvent unless the molecule is known to be highly polar/ionizable.
Aqueous delivery: after preparing a concentrated organic stock, dilute into buffered media (e.g., PBS, HEPES) with vigorous mixing to a final ≤0.1–1% v/v DMSO for most cells/enzymes.
Selection tips
Analytical work (LC–MS): choose acetonitrile/water or methanol/water with 0.1% formic acid or ammonium buffers as appropriate for ionization; test positive/negative modes.
Crystallization or solid recovery: screen EtOAc/hexanes, MeOH/Et2O, or MeCN/Et2O pairs for small organics; tailor to polarity once the structure is confirmed.
Avoid strongly basic or acidic solvents unless stability is demonstrated; unknown structures may be sensitive to hydrolysis or oxidation.
Documentation
Record exact solvent lot, water content, and final vehicle percentage in all biological or analytical reports to ensure reproducibility.
Storage and Reconstitution
Item-specific
Storage Conditions: Room temperature (from Product Data).
Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
Appearance / Form: Not specified for this item; refer to CoA/Spec Sheet.
General guidance for small-molecule library compounds
On receipt, store in a cool, dry place, protected from light. If supplied in microplates or septum vials, minimize headspace exposure and recap promptly.
For long-term storage of solutions, prepare single-use aliquots (e.g., 10–100 µL) in high-quality DMSO; store at −20 to −80 °C and avoid repeated freeze–thaw cycles.
Reconstitution: Start with anhydrous DMSO to target 10–50 mM; mix thoroughly. If aqueous working solutions are needed, dilute the DMSO stock into buffer with vigorous mixing to avoid precipitation.
Stability: Monitor by LC–MS/UPLC at defined intervals; note any color change, precipitation, or assay drift.
Labeling
Include product name (GNE-616), concentration, solvent, preparation date, and operator initials on all vials/plates.
For any item-specific stability windows, solution shelf life, or light/moisture sensitivities, consult the lot-specific CoA/SDS.
Structure and Identity
Item-specific (from Product Data)
Product Name: GNE-616 (SKU: G610616)
Grade: Moligand™
CAS: G610616 (catalog identifier provided; not a standard CAS Registry number)
CID: 138393286 (as provided)
InChIKey: 424877 (as supplied)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula / Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Notes on structure
A definitive 2D/3D structure is not provided in the Product Data. Without a SMILES/InChI or confirmed structural diagram, specific functional groups, ring systems, or stereochemical elements cannot be described for this item.
For unambiguous structural identity and spectral confirmation (e.g., 1H/13C NMR, HRMS), please consult the item’s CoA/SDS or request the analytical package from Aladdin Scientific.
General guidance (chemistry background)
“GNE-” prefixes are commonly used in the literature for discovery-stage small molecules originating from internal pipelines; however, naming conventions vary and are not definitive identifiers of mechanism or chemotype.
If you are linking to external identifiers (e.g., PubChem CID 138393286), verify that the external record matches the exact supplier lot by cross-checking InChIKey, formula, and spectra. Discrepancies between catalog placeholders and registry entries can occur and should be resolved before experimental use.
Synthetic Utility
Item-specific functional groups and derivatization handles are not provided, therefore no concrete synthetic transformations can be recommended for this compound.
General considerations for library compounds
If structure is available, map modifiable positions for rapid analog generation (e.g., amide coupling, SNAr, Suzuki–Miyaura cross-coupling) to drive SAR.
Establish a diversity-oriented synthesis plan around the core scaffold (ring substitutions, linker swaps, heteroatom edits) and prioritize tractable routes that tolerate late-stage diversification.
Implement purification and analytics tuned to the scaffold: normal-/reverse-phase chromatography, SPE cleanup, and stability-indicating LC methods.
Recommendation
Obtain or confirm the structure (SMILES/InChI) and spectra for this specific lot before attempting derivatization or route scouting. Without this, retrosynthetic planning is speculative.
Target Specificity
Item-specific target, pathway, or protein family selectivity information is not provided for GNE-616 in the Product Data.
No antigen/epitope, isotype/clone, or species reactivity applies (this is a small molecule, not an antibody or protein reagent).
If external sources are consulted via the provided CID, verify that the structure and identifiers exactly match this supplier lot before attributing any target or mechanism claims.
Need help choosing the grade?
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
